Diosmetin Targeted at Peroxisome Proliferator-Activated Receptor Gamma Alleviates Advanced Glycation End Products Induced Neuronal Injury

The present study aimed to evaluate the role of diosmetin in alleviating advanced glycation end products (AGEs)-induced Alzheimer’s disease (AD)-like pathology and to clarify the action mechanisms. Before stimulation with AGEs (200 μg/mL), SH-SY5Y cells were treated with diosmetin (10 μmol/L), incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Mei Chou, Liu, Wayne Young, Liou, Shorong-Shii, Liu, I-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183070/
https://www.ncbi.nlm.nih.gov/pubmed/35684047
http://dx.doi.org/10.3390/nu14112248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183070/
https://www.ncbi.nlm.nih.gov/pubmed/35684047
http://dx.doi.org/10.3390/nu14112248

Ejemplares similares